A theme the specialists are building · as of 2026-09-19
Specialty Pharma Rotation
This is a large-cap biopharma allocation trade toward durable specialty portfolios navigating patent cliffs through pipeline replacement.
11 proven specialist funds in4 stocks in the basket1 Early Conviction2 Consensus1 Tracked
BMYEarly ConvictionPatent-cliff management via oncology and immunology portfolio — one name revealed, on us
The other 3 names, each with its role and stage, are inside.See the basket — free account →
Themes are read from quarterly filings of proven specialist funds plus the options tape. Evidence, not advice. Track our public record on The Book.